Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 49

1.

Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the data collection on adverse events of anti-HIV drugs (D:A:D) study.

Worm SW, Sabin C, Weber R, Reiss P, El-Sadr W, Dabis F, De Wit S, Law M, Monforte AD, Friis-Møller N, Kirk O, Fontas E, Weller I, Phillips A, Lundgren J.

J Infect Dis. 2010 Feb 1;201(3):318-30. doi: 10.1086/649897.

PMID:
20039804
2.

Metabolic syndrome associated with HIV and highly active antiretroviral therapy.

Barbaro G, Iacobellis G.

Curr Diab Rep. 2009 Feb;9(1):37-42. Review.

PMID:
19192423
3.

Relation of epicardial fat and alanine aminotransferase in subjects with increased visceral fat.

Iacobellis G, Pellicelli AM, Grisorio B, Barbarini G, Leonetti F, Sharma AM, Barbaro G.

Obesity (Silver Spring). 2008 Jan;16(1):179-83. doi: 10.1038/oby.2007.50.

4.

Relation of subepicardial adipose tissue to carotid intima-media thickness in patients with human immunodeficiency virus.

Iacobellis G, Pellicelli AM, Sharma AM, Grisorio B, Barbarini G, Barbaro G.

Am J Cardiol. 2007 May 15;99(10):1470-2. Epub 2007 Apr 5.

PMID:
17493483
5.
6.

Prevalence of dilated cardiomyopathy in HIV-infected African patients not receiving HAART: a multicenter, observational, prospective, cohort study in Rwanda.

Twagirumukiza M, Nkeramihigo E, Seminega B, Gasakure E, Boccara F, Barbaro G.

Curr HIV Res. 2007 Jan;5(1):129-37.

PMID:
17266564
7.

Highly active antiretroviral therapy compared with HAART and bosentan in combination in patients with HIV-associated pulmonary hypertension.

Barbaro G, Lucchini A, Pellicelli AM, Grisorio B, Giancaspro G, Barbarini G.

Heart. 2006 Aug;92(8):1164-6. No abstract available.

8.

HIV-associated renal diseases and highly active antiretroviral therapy-induced nephropathy.

Röling J, Schmid H, Fischereder M, Draenert R, Goebel FD.

Clin Infect Dis. 2006 May 15;42(10):1488-95. Epub 2006 Apr 11. Review.

PMID:
16619164
9.
10.

Impact of human immunodeficiency virus infection on cardiovascular disease in Africa.

Ntsekhe M, Hakim J.

Circulation. 2005 Dec 6;112(23):3602-7. Review.

11.

Carotid artery intima-media thickness and HIV infection: traditional risk factors overshadow impact of protease inhibitor exposure.

Currier JS, Kendall MA, Zackin R, Henry WK, Alston-Smith B, Torriani FJ, Schouten J, Mickelberg K, Li Y, Hodis HN; AACTG 5078 Study Team..

AIDS. 2005 Jun 10;19(9):927-33.

12.

Change in atherosclerosis progression in HIV-infected patients: ANRS Aquitaine Cohort, 1999-2004.

Thiébaut R, Aurillac-Lavignolle V, Bonnet F, Ibrahim N, Cipriano C, Neau D, Dupon M, Dabis F, Mercié P; Groupe d'Epidemiologie Clinique du Sida en Aquitaine (GECSA)..

AIDS. 2005 Apr 29;19(7):729-31.

PMID:
15821400
13.

Cardiovascular risk and body-fat abnormalities in HIV-infected adults.

Grinspoon S, Carr A.

N Engl J Med. 2005 Jan 6;352(1):48-62. Review. No abstract available.

14.

Bosentan for the treatment of human immunodeficiency virus-associated pulmonary arterial hypertension.

Sitbon O, Gressin V, Speich R, Macdonald PS, Opravil M, Cooper DA, Fourme T, Humbert M, Delfraissy JF, Simonneau G.

Am J Respir Crit Care Med. 2004 Dec 1;170(11):1212-7. Epub 2004 Aug 18.

PMID:
15317666
15.

Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV infection.

Hsue PY, Lo JC, Franklin A, Bolger AF, Martin JN, Deeks SG, Waters DD.

Circulation. 2004 Apr 6;109(13):1603-8. Epub 2004 Mar 15.

16.

An open-label, prospective, observational study of the incidence of coronary artery disease in patients with HIV infection receiving highly active antiretroviral therapy.

Barbaro G, Di Lorenzo G, Cirelli A, Grisorio B, Lucchini A, Hazra C, Barbarini G.

Clin Ther. 2003 Sep;25(9):2405-18. Erratum in: Clin Ther. 2004 Jan;26(1):175.

PMID:
14604740
17.

Increased risk of myocardial infarction with duration of protease inhibitor therapy in HIV-infected men.

Mary-Krause M, Cotte L, Simon A, Partisani M, Costagliola D; Clinical Epidemiology Group from the French Hospital Database..

AIDS. 2003 Nov 21;17(17):2479-86.

PMID:
14600519
18.

Vasculitic syndromes in HIV-infected patients.

Barbaro G.

Adv Cardiol. 2003;40:185-96. Review. No abstract available.

PMID:
14533554
19.

Cardiovascular pathology in AIDS.

Klatt EC.

Adv Cardiol. 2003;40:23-48. Review. No abstract available.

PMID:
14533545
20.

Guidelines for the evaluation and management of dyslipidemia in human immunodeficiency virus (HIV)-infected adults receiving antiretroviral therapy: recommendations of the HIV Medical Association of the Infectious Disease Society of America and the Adult AIDS Clinical Trials Group.

Dubé MP, Stein JH, Aberg JA, Fichtenbaum CJ, Gerber JG, Tashima KT, Henry WK, Currier JS, Sprecher D, Glesby MJ; Adult AIDS Clinical Trials Group Cardiovascular Subcommittee.; HIV Medical Association of the Infectious Disease Society of America..

Clin Infect Dis. 2003 Sep 1;37(5):613-27. Epub 2003 Aug 15. Review. No abstract available.

PMID:
12942391

Supplemental Content

Support Center